Docket #: S06-455
Monoclonal Antibody against human LMO2 Antigen
This antibody is directed against the human LMO2 antigen, which is expressed as a transcription factor in certain lymphomas and leukemias. We have recently shown that it identifies those lymphomas derived from germinal center B cells. These lymphomas are the subset with a better response to therapy and a better prognosis.
LMO2 gene translocations have been found in a subset of human T cell acute leukemias.
The LMO2 gene was a site of specific integration of gene therapy vectors which caused leukemia.
Applications
- Useful in classification of human lymphoma and leukemia.
- Useful in establishing prognosis in human lymphoma and leukemia
Similar Technologies
-
293T Cell Line (ATCC: CRL-3216) S97-079293T Cell Line (ATCC: CRL-3216)
-
Multidrug (Pleiotropic) Resistant Cell Line, MES-SA/Dx5 S01-102Multidrug (Pleiotropic) Resistant Cell Line, MES-SA/Dx5
-
Rat Antibodies (TR310; R1-2; 6C3) S90-102Rat Antibodies (TR310; R1-2; 6C3)